# Evaluation of GLR2007 for Advanced Solid Tumors

> **NCT04444427** · PHASE1,PHASE2 · COMPLETED · sponsor: **Gan and Lee Pharmaceuticals, USA** · enrollment: 19 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Glioblastoma Multiforme

## Interventions

- **DRUG:** GLR2007

## Key facts

- **NCT ID:** NCT04444427
- **Lead sponsor:** Gan and Lee Pharmaceuticals, USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-15
- **Primary completion:** 2022-07-29
- **Final completion:** 2022-07-29
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2022-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04444427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04444427, "Evaluation of GLR2007 for Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04444427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*